# Psychoneuroimmunology Therapy in Uncontrolled Diabetic Patients: A Quasi-experimental Study

Study · id `cardio:ct-nct02536820` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02536820](<https://clinicaltrials.gov/study/NCT02536820>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02536820

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

## Technical summary

Registry record NCT02536820. Non-randomized; single masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2016-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT02536820, source copy `cardio:ctgov-nct02536820-2015-09-01`, retrieved 2026-10-26)
- Start date: 2015-09 (registry gives no type) (ClinicalTrials.gov record NCT02536820, source copy `cardio:ctgov-nct02536820-2015-09-01`, retrieved 2026-10-26)
- Primary completion: 2016-09 (anticipated) (ClinicalTrials.gov record NCT02536820, source copy `cardio:ctgov-nct02536820-2015-09-01`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02536820-2015-09-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Psychoneuroimmunology Therapy in Uncontrolled Diabetic Patients: A Quasi-experimental Study
- Acronym: PNIT
- Condition: Diabetes Mellitus, Type 2
- Intervention (Behavioral): psychoneuroimmune therapy
- Intervention (Drug): Conventional treatment
- Lead sponsor: Fundación Salutia
- Lead sponsor class: OTHER
- Collaborator: Coomeva E.P.S
- Collaborator class: UNKNOWN
- Collaborator: Sinergia
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: 391e3801091590dea40f30feb997fd8759f9e37a48e4e40af7b42421a896b678
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
